As part of IEN’s mission to develop and cultivate the next generation of technologists, our team hosts numerous professional development lectures and short courses. Course and lecture topics include cleanroom fabrication techniques, advanced lithography techniques, market sector applications of nanotechnology research, and seminars on nanotechnology as it relates to other fields of engineering. These events are open to both GA Tech and other institutions’ researchers and educators, as well as to those in industry and the interested public.
VIRTUAL EVENT SERIES!
Fall 2020 NANOFANS Webinar Series
“Point-of-Care Technology in Healthcare
October 1-29, 2020 | 11:00 am - 12:00 pm (EDT)
NanoFANS (Focusing on Advanced Nanobio- Systems) program will be offered in a weekly webinar format during the month of October. The focus of this event will be “Point-of-Care Technology in Healthcare.” Point of Care Technology (POCT) is a fast-emerging field of medical diagnostics performed outside of the clinical laboratory, providing healthcare professionals with actionable information to allow rapid clinical decision-making. POCT devices support remote patient monitoring, reduce diagnosis times, and enable easier access to healthcare in remote and resource-poor settings due to the field-deployable nature of these devices. POCT are enabled by research advancements in nano- and micro-technologies, including development of microelectromechanical systems (MEMs), biosensors, microfluidics, and smartphone-based or cloud-based systems.
October 22: Carlos Moreno , Professor | Emory School of Medicine
The ResonanceDx Bulk Acoustic Resonance Sensing Platform
October 29: Liedong Mao, Professor |School of Electrical and Computer Engineering, University of Georgia
Ferrohydrodynamic Isolation of Circulating Tumor Cells and Exomes
Please click the link, https://tinyurl.com/fall2020nanofansflyer to know more about the webinar dates, talk abstracts, speaker bios, and registration. A meeting URL will be sent to all those registered prior to the event.
NanoFANS Fall 2020 Series Session 4 | The ResonanceDx Bulk Acoustic Resonance Sensing Platform
October 22, 2020 @ 11am | The ResonanceDx Bulk Acoustic Resonance Sensing Platform
Carlos Moreno | Professor, Emory School of Medicine
Abstract: As the global coronavirus pandemic continues, there is an urgent clinical and epidemiological need to be able to assess whether or not someone has contracted COVID19. The ResonanceDx Bulk Acoustic Resonance Sensing (BARS) platform detects the shifts in the piezoelectric acoustic resonant frequencies that occur upon antibody-antigen binding and is approximately an order of magnitude more sensitive than standard ELISA detection methods. Moreover, this approach provides results in approximately 5 minutes with no sample processing or expensive or hard to manufacture reagents, enabling the use of whole blood or saliva. The applications for such a rapid point-of-care COVID19 diagnostic test are numerous, including identifying exposed healthcare workers, safely facilitating regular procedures from dental visits to elective surgery, allowing family members to visit hospitals or nursing homes, allowing non-essential workers to return to work, college students to campus, safe travel on airlines or cruises, or admission to large gatherings for members of the general public.
Bio: Dr. Moreno obtained his B.S. and M.S. in Aeronautics and Astronautics from MIT, and worked for NASA before he earned his PhD in Genetics and Molecular Biology from Emory University in 1998. He is Associate Professor of Pathology & Laboratory Medicine and Biomedical Informatics at Emory University, where he is a member of the Winship Cancer Institute. He specializes in cancer bioinformatics and cancer genomics, and his laboratory has used whole genome expression analysis and next-generation sequencing to identify biomarkers of aggressive disease in prostate cancer. He is Section Editor-in-Chief of the Cancer Biomarkers section of the journal Cancers. He is a co-inventor on a patent application for a system to detect biomarkers using piezoelectric resonators. In 2017, he co-founded ResonanceDx to develop rapid, point-of-care diagnostic devices.